logo
  

Moderna, Tabuk Pharma Ink Deal To Commercialize Moderna's COVID-19 Vaccine In Saudi Arabia

Biotechnology company Moderna, Inc. (MRNA) and Tabuk Pharmaceutical Manufacturing Co, a fully owned subsidiary of Saudi pharmaceuticals company Astra Industrial Group, announced Friday an agreement to commercialize the Moderna COVID-19 Vaccine and future variant-specific booster candidates, if authorized, in Saudi Arabia for 2021 and 2022.

Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorization for the Moderna COVID-19 vaccine in Saudi Arabia.

Beyond the Moderna COVID-19 Vaccine and Moderna's updated variant booster candidates, the agreement also gives Tabuk the possibility to discuss opportunities to distribute other Moderna mRNA products if authorized in the future.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting its financial results for the second quarter on Thursday, Kellogg Co. (K) reaffirmed its currency-neutral adjusted earnings growth guidance for the full year 2021. For fiscal 2021, the company now projects currency-neutral adjusted earnings per share growth of about 1 to 2 percent... Moderna Inc. (MRNA) reported a profit for the second quarter compared to a loss in the previous year, reflecting surging revenues on commercial sales of the company's COVID-19 vaccine in the U.S. Quarterly earnings per share and revenues topped analysts' expectations. The company raised its 2021 sales forecast for its COVID-19 vaccine. New Widetech has recalled dehumidifiers sold under various brand names citing fire and burn risks, the U.S. Consumer Product Safety Commission said. The brand names include AeonAir, Amana, Haier, Honeywell, and Whirlpool, among others. The recall was initiated after New Widetech received reports of 107 incidents of the recalled dehumidifiers overheating and/or catching fire.
Follow RTT